申请人:Pfizer Inc.
公开号:US04468351A1
公开(公告)日:1984-08-28
A process for the debromination of 6-monobromo- and 6,6-dibromopenicillanic acid, and various derivatives thereof, by the action of a bisulfite salt. The debrominated compounds produced find various utilities, as beta-lactamase inhibitors useful in therapy in combination with known beta-lactam antibiotics, or as intermediates in the further synthesis of useful beta-lactam compounds.
一种通过亚硫酸氢盐的作用对6-单溴-和6,6-二溴-青霉酸及其各种衍生物进行去溴化的方法。产生的去溴化化合物具有各种用途,如与已知的β-内酰胺酶抑制剂一起在治疗中使用的β-内酰胺酶抑制剂,或作为有用的β-内酰胺化合物的进一步合成中间体。